CRVS Similar Chart Price Prediction
The price of CRVS is predicted to go up 10.53%, based on the high correlation periods with TAP. The similarity of these two price pattern on the periods is 98.47%.
CRVS
TAP
Up: 10.53%Similarity: 98.47%
CRVS Revenue Forecast
CRVS EPS Forecast
CRVS FAQs
What is CRVS eps forecast for next quarter？
CRVS Analyst's Forecast
Jeff Jones
Oppenheimer
Buy
2024-11-13
Price Target
$8 → $14
Upside
+57.84%
Oppenheimer analyst Jeff Jones raised the firm's price target on Corvus Pharmaceuticals to $14 from $8 and keeps an Outperform rating on the shares following quarterly results. The firm is highly encouraged by management's enthusiasm for the upcoming atopic dermatitis readout in December. Cash remains constrained given the level of clinical activity, with Q3-ending cash reported at $42M, providing runway into early 2026, by Oppenheimer's estimate.
